Diabetic retinopathy (DR) is one of several diabetes related complications and now is the leading cause of new onset blindness among individuals aged 20–64 years old.In the study, Streptozotocin-induced diabetic rats were divided into two treatment groups based on the route of administration of treatment — oral treatment group and topical treatment group.
